Science Explorer Back to mapMap
Discussion
Researcher · Caris Life Sciences (United States) · United States

David B. Spetzler

David B. Spetzler publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers and Extracellular vesicles in disease.

ORCID 0000-0002-9531-0970 OpenAlex
World rank
#219,086
of 7,710,434 ranked researchers
Rank in United States
#81,066
of 1,627,098
Works
340
Citations
10k
Citations per work
29.4
h-index
28
i10-index 61Top 17% in Molecular Biology
David B. Spetzler

What does David B. Spetzler research?

David B. Spetzler's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (37%).

Health Sciences: 132 works · 38.8% of their workMedicine: 132 works · 38.8% of their workOncology: 59 works · 17.5% of their workPulmonary and Respiratory Medicine: 38 works · 11.1% of their workPathology and Forensic Medicine: 21 works · 6.2% of their workGenetics: 14 works · 4.0% of their workLife Sciences: 126 works · 37.0% of their workBiochemistry, Genetics and Molecular Biology: 126 works · 37.0% of their workMolecular Biology: 78 works · 23.0% of their workCancer Research: 48 works · 14.0% of their workEverything else: 82 works · 24.2% of their workTHEIR WORKDavid B. Spetzler340works
Life Sciences37%Health Sciences39%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine13238.8%
    1. Biochemistry, Genetics and Molecular Biology12637.0%
  3. Everything else8224.2%
  1. 1Molecular Biology23% of their works
  2. 2Oncology18% of their works
  3. 3Cancer Research14% of their works
  4. 4Pulmonary and Respiratory Medicine11% of their works
  5. 5Pathology and Forensic Medicine6% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe David B. Spetzler's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Tumor Microenvironment, Cancer, Immune Checkpoint Blockade, PD-1 and PD-L1 and Exosomes.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy742 topics
  2. Cancer Genomics601 topic
  3. Mutational Signatures601 topic
  4. Tumor Microenvironment452 topics
  5. Cancer412 topics
  6. Immune Checkpoint Blockade291 topic
  7. PD-1 and PD-L1291 topic
  8. Exosomes251 topic
  9. Extracellular Vesicles251 topic
  10. Microsatellite Instability241 topic
  11. Molecular Characterization241 topic
  12. Glioblastoma221 topic
  13. Temozolomide221 topic
  14. Cell Death161 topic
  15. Ferroptosis161 topic
  16. ALK Inhibitors141 topic
  17. EGFR Mutations141 topic
  18. DNA nanotechnology131 topic
  19. Self-Assembly131 topic

Where does David B. Spetzler work?

David B. Spetzler's main affiliation in the publication record is Caris Life Sciences (United States), United States.

How many publications and citations does David B. Spetzler have?

OpenAlex counts 340 works and 10,001 citations for David B. Spetzler, an h-index of 28, ranking #219,086 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about David B. Spetzler. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.